Novel anti-cancer medicine could improve current therapy for ER+ breast cancer
The anti-cancer medicine venetoclax could improve the current therapy for estrogen receptor-positive breast cancer - the most common form of breast cancer in Australia - according to preclinical studies led by Walter and Eliza Hall Institute researchers.
No hay comentarios:
Publicar un comentario